Centessa Pharmaceuticals (CNTA) Deferred Taxes (2022 - 2026)
Centessa Pharmaceuticals (CNTA) reported Deferred Taxes of $828000.0 for Q1 2026, down 16.78% year-over-year from $995000.0 in Q1 2025, and up 255.36% quarter-over-quarter from $233000.0 in Q4 2025.
Centessa Pharmaceuticals (CNTA) Deferred Taxes (2022 - 2026) Analysis & Trends
Centessa Pharmaceuticals (CNTA) has 5 years of Deferred Taxes data on file, last reported at $828000.0 in Q1 2026.
- Deferred Taxes for Q1 2026 came in at $828000.0, down 16.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (down 27.13% YoY), and the FY2025 annual result was $2.5 million, down 5.43% from the prior year.
- Deferred Taxes rose to $828000.0 in Q1 2026 per CNTA's latest filing, from $233000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $1.3 million in Q3 2024 and troughed at -$23.5 million in Q2 2023.
- A 5-year average of -$1.7 million and a median of $326500.0 in 2024 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2023 and 2024: Deferred Taxes tumbled 2040.74% in 2023, then surged 367.11% in 2024.
- A 5-year view of Deferred Taxes shows it stood at -$2.8 million in 2022, then jumped by 94.63% to -$149000.0 in 2023, then surged by 367.11% to $398000.0 in 2024, then tumbled by 41.46% to $233000.0 in 2025, then soared by 255.36% to $828000.0 in 2026.
- Business Quant data shows CNTA's Deferred Taxes at $828000.0 in Q1 2026, $233000.0 in Q4 2025, and $255000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Centessa Pharmaceuticals | 6.15 Bn | 6.15 Bn | - | 828,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 828,000.00 |
| Dec 31, 2025 | 233,000.00 |
| Sep 30, 2025 | 255,000.00 |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 995,000.00 |
| Dec 31, 2024 | 398,000.00 |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 567,000.00 |
| Mar 31, 2024 | 434,000.00 |
| Dec 31, 2023 | -149,000.00 |
| Sep 30, 2023 | -2.89 Mn |
| Jun 30, 2023 | -23.49 Mn |
| Dec 31, 2022 | -2.77 Mn |
| Sep 30, 2022 | -135,000.00 |